March 14, 2018 / 9:41 PM / 3 months ago

BRIEF-Inovio Pharmaceuticals Reports Qtrly ‍Net Loss Attributable To Stockholders Of $0.24 Per Basic Share​

March 14 (Reuters) - Inovio Pharmaceuticals Inc:

* INOVIO PHARMACEUTICALS REPORTS 2017 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS

* Q4 REVENUE $8.8 MILLION VERSUS I/B/E/S VIEW $7.5 MILLION

* QTRLY ‍NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.24 PER BASIC SHARE​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below